ftc pharmacy benefit managers - Search News

Pharmacy managers inflated drug prices by $7.3 billion

USA Today · 8h

FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain

The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S.

Hosted on MSN · 2h

Report: 'Pharmacy Benefit Managers' profited billions by raising prices of 'specialty drugs'

The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without substantiating evidence."

13hon MSN

Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

1don MSN

PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results